Adults with glomerular diseases—which affect the kidney's filtering units where blood is cleaned—face a high risk of developing heart problems, according to a study that will be presented online during ASN Kidney Week ...
Oct 23, 2020
0
2
(HealthDay)—From 2010 to 2014 there was an increase in use of diabetes medications, including sulfonylureas and dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), among patients with diabetic nephropathy, according to ...
Mar 27, 2017
0
0
(HealthDay)—In patients with membranous nephropathy at high risk for progressive disease, rituximab is noninferior to cyclosporine in inducing complete or partial remission of proteinuria at 12 months and is superior in ...
Jul 17, 2019
0
1
SGLT2 inhibitors (gliflozins) were developed as oral antidiabetics. They enhance urinary glucose excretion by inhibiting SGLT-2 (sodium-dependent glucose co-transporter-2) in the renal tubuli. The discovery of kidney benefits ...
Jun 7, 2021
0
3
Urine is one of the attractive sources for early and sensitive biomarker discovery since it can accumulate and reflect changes in the human body while being collected non-invasively. However, analysis of the urine proteome ...
Jun 16, 2023
0
2
Forty-eight international experts on membranous nephropathy have co-authored a consensus report that calls for a new method of classifying diagnoses of the syndrome. They say the change would result in greater accuracy in ...
Oct 18, 2023
0
1
